Department of Medicine

June 10, 2024

Office of Outpatient Referral Assistance announces leadership appointments 

The office ensures that patients receive timely and appropriate medical attention and optimizes uncompensated care delivery through case reviews and determinations that have dramatically increased over the last four years.

By Kathy Whitney
June 10, 2024

Vanderbilt researchers establish biomedical informatics training program in Mozambique

Building sustainable biomedical informatics training and research capacity to address gaps in Mozambique’s national HIV response will help the country leverage newer data-driven and genetics-based approaches for personalized HIV care and molecular epidemiology of the disease.

By Kristen Centers
Brooke Emerling, PhD, and Raymond Blind, PhD (seated, in foreground) at a 2023 scientific symposium they organized. Standing next to Blind is Hua Ya, PhD, from the City of Hope Comprehensive Cancer Center. Behind him in the light blue shirt is Emilio Hirsch, PhD, from the University of Torino, Italy.
June 7, 2024

Discovery raises hopes for new cancer therapy

The study connected the Hippo signaling pathway to phosphoinositides, a particular type of lipid, or fat molecule, which regulates cell functions that are critical in cancer, obesity and diabetes.

By Bill Snyder
Fei Ye, PhD, MSPH
June 6, 2024

Fei Ye selected as a fellow of the American Statistical Association

Fei Ye is the first woman among VUMC’s Biostatistics faculty to be selected as an ASA fellow. She’ll be among 47 new ASA fellows inducted in August at the Joint Statistical Meetings.

By Paul Govern
Graduate student Taralynn Mack, left, pipettes a sample while Alexander Bick, MD, graduate student Hannah Poisner, and Celestine Wanjalla, MD, PhD, look on.
June 4, 2024

Research raises hope for treating potentially lethal blood condition

Roughly 1 in 10 people over age 70 will develop CHIP, an explosive, clonal growth of abnormal blood cells that increases risk of blood cancers and death from cardiovascular, lung and liver disease.

By Bill Snyder
Photo caption: Jonathan Mosley, MD, PhD, left, Scott Borinstein, MD, PhD, John Shelley, and Vivian Kawai, MD, MPH, are studying how genetic variation not related to disease affects clinical decisions. (photo by Susan Urmy)
June 3, 2024

Genetic variation associated with low white blood cell count impacts clinical decisions

People whose white blood cell levels are near the edge of the “healthy” reference range will hit a clinical decision point that has consequences such as diagnostic procedures and altered treatments.

By Leigh MacMillan